Literature DB >> 9085269

Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil.

J Kim1.   

Abstract

The precursor protein of the non-A beta component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system. The physiological function of NACP is not known, but the localization of NACP at presynaptic nerve terminals suggests that it may be involved in the neuronal function. To better understand the physiological function of NACP and its role in the pathogenesis of Alzheimer's disease (AD), the biochemical and biophysical properties fo NACP were investigated. The NACP behaves abnormally on FPLC gel-filtration chromatography with the apparent molecular mass of 70 kDa, and the results from chemical cross-linking, limited proteolysis and CD experiments suggest that significant parts of NACP may be unfolded. The abnormal hydrodynamic behavior and extreme protease sensitivity of NACP could result from the extended structure which may be related to the physiological function and pathological role of this protein in the development of AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085269

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  24 in total

1.  Definition of a molecular pathway mediating α-synuclein neurotoxicity.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 2.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

3.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

Authors:  A Takeda; M Mallory; M Sundsmo; W Honer; L Hansen; E Masliah
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Structural changes in alpha-synuclein affect its chaperone-like activity in vitro.

Authors:  T D Kim; S R Paik; C H Yang; J Kim
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

5.  Copper(II)-induced self-oligomerization of alpha-synuclein.

Authors:  S R Paik; H J Shin; J H Lee; C S Chang; J Kim
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 6.  The biochemistry of Alzheimer's disease.

Authors:  G J Stege; G J Bosman
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

7.  Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast.

Authors:  Cheryl Dixon; Neal Mathias; Richard M Zweig; Donnie A Davis; David S Gross
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

Review 8.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

9.  Peroxidative aggregation of alpha-synuclein requires tyrosines.

Authors:  Alina Olteanu; Gary J Pielak
Journal:  Protein Sci       Date:  2004-09-30       Impact factor: 6.725

10.  Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system.

Authors:  V L Buchman; H J Hunter; L G Pinõn; J Thompson; E M Privalova; N N Ninkina; A M Davies
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.